Q-Sera CEO Michael Grant added, “Japan has a history of innovation in blood collection tubes with Terumo Corporation a leader ...

Dyadic Applied BioSolutions (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company ...

PRESS RELEASE Strategic research collaboration to advance MTx’s recombinant polyclonal IgG technologyAgreement includes R&D funding for exploratory work, technology access and, assuming exercise of ...

CSL has gotten the Memo about the value of recombinant polyclonal immunoglobulin (IgG) antibodies.  | The deal allows CSL to ...

LAUSANNE, Switzerland, Feb. 18, 2026 (GLOBE NEWSWIRE) -- NewBiologix S.A., a biotechnology company advancing recombinant ...

Dyadic Applied BioSolutions ("Dyadic", "we", "us", "our", or the "Company") (NASDAQ: DYAI), a global biotechnology company producing precision-engineered ...

EpitogenX and Attomarker sign co-development agreement to advance precision immunology diagnostics in multiple diseases ...

"This is the moment where planning becomes production," said Kim Thompson, Kraig Labs CEO and Founder. "Our 2026 roadmap was built around disciplined expansion, operational efficiency, and multi-ton ...

Vaxart, Inc. (OTCQX: VXRT), a clinical-stage biotechnology company developing a range of oral vaccines based on its proprietary delivery platform, today announced that members of the management team ...

It already exists in the natural world. Now, thanks to breakthroughs in genetic engineering, scientists have created “supersilk.” And it’s poised to upgrade far more than our clothing.

GSK’s Arexvy associated with reductions in certain RSV-related risks including heart attack, stroke and severe flare-ups of COPD and asthma, real world study shows: London, UK T ...

AsymBio, a subsidiary of Asymchem Group (stock code: 002821.SZ / 6821.HK), announced that it has established integrated ...